The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Safety Lancets Market Research Report 2025
Synopsis
Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor’s offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.
The global Safety Lancets market was valued at US$ 585.6 million in 2023 and is anticipated to reach US$ 858.5 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
Global key players of safety lancets include HTL-STREFA, BD, Roche, etc. The top three players hold a share about 33%. Americas is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 31% and 23%, separately.
This report aims to provide a comprehensive presentation of the global market for Safety Lancets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Safety Lancets.
Report Scope
The Safety Lancets market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Safety Lancets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Safety Lancets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
Segment by Type
Safety Lancets with Needle
Safety Lancets with Blade
Segment by Application
Hospital & Clinics
Home
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Safety Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Safety Lancets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor’s offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.
The global Safety Lancets market was valued at US$ 585.6 million in 2023 and is anticipated to reach US$ 858.5 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
Global key players of safety lancets include HTL-STREFA, BD, Roche, etc. The top three players hold a share about 33%. Americas is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 31% and 23%, separately.
This report aims to provide a comprehensive presentation of the global market for Safety Lancets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Safety Lancets.
Report Scope
The Safety Lancets market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Safety Lancets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Safety Lancets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
Segment by Type
Safety Lancets with Needle
Safety Lancets with Blade
Segment by Application
Hospital & Clinics
Home
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Safety Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Safety Lancets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Safety Lancets Market Overview
1.1 Product Overview and Scope of Safety Lancets
1.2 Safety Lancets Segment by Type
1.2.1 Global Safety Lancets Market Value Comparison by Type (2024-2030)
1.2.2 Safety Lancets with Needle
1.2.3 Safety Lancets with Blade
1.3 Safety Lancets Segment by Application
1.3.1 Global Safety Lancets Market Value by Application: (2024-2030)
1.3.2 Hospital & Clinics
1.3.3 Home
1.3.4 Other
1.4 Global Safety Lancets Market Size Estimates and Forecasts
1.4.1 Global Safety Lancets Revenue 2019-2030
1.4.2 Global Safety Lancets Sales 2019-2030
1.4.3 Global Safety Lancets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Safety Lancets Market Competition by Manufacturers
2.1 Global Safety Lancets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Safety Lancets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Safety Lancets Average Price by Manufacturers (2019-2024)
2.4 Global Safety Lancets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Safety Lancets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Safety Lancets, Product Type & Application
2.7 Safety Lancets Market Competitive Situation and Trends
2.7.1 Safety Lancets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Safety Lancets Players Market Share by Revenue
2.7.3 Global Safety Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Safety Lancets Retrospective Market Scenario by Region
3.1 Global Safety Lancets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Safety Lancets Global Safety Lancets Sales by Region: 2019-2030
3.2.1 Global Safety Lancets Sales by Region: 2019-2024
3.2.2 Global Safety Lancets Sales by Region: 2025-2030
3.3 Global Safety Lancets Global Safety Lancets Revenue by Region: 2019-2030
3.3.1 Global Safety Lancets Revenue by Region: 2019-2024
3.3.2 Global Safety Lancets Revenue by Region: 2025-2030
3.4 North America Safety Lancets Market Facts & Figures by Country
3.4.1 North America Safety Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Safety Lancets Sales by Country (2019-2030)
3.4.3 North America Safety Lancets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Safety Lancets Market Facts & Figures by Country
3.5.1 Europe Safety Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Safety Lancets Sales by Country (2019-2030)
3.5.3 Europe Safety Lancets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Safety Lancets Market Facts & Figures by Country
3.6.1 Asia Pacific Safety Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Safety Lancets Sales by Country (2019-2030)
3.6.3 Asia Pacific Safety Lancets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Safety Lancets Market Facts & Figures by Country
3.7.1 Latin America Safety Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Safety Lancets Sales by Country (2019-2030)
3.7.3 Latin America Safety Lancets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Safety Lancets Market Facts & Figures by Country
3.8.1 Middle East and Africa Safety Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Safety Lancets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Safety Lancets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Safety Lancets Sales by Type (2019-2030)
4.1.1 Global Safety Lancets Sales by Type (2019-2024)
4.1.2 Global Safety Lancets Sales by Type (2025-2030)
4.1.3 Global Safety Lancets Sales Market Share by Type (2019-2030)
4.2 Global Safety Lancets Revenue by Type (2019-2030)
4.2.1 Global Safety Lancets Revenue by Type (2019-2024)
4.2.2 Global Safety Lancets Revenue by Type (2025-2030)
4.2.3 Global Safety Lancets Revenue Market Share by Type (2019-2030)
4.3 Global Safety Lancets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Safety Lancets Sales by Application (2019-2030)
5.1.1 Global Safety Lancets Sales by Application (2019-2024)
5.1.2 Global Safety Lancets Sales by Application (2025-2030)
5.1.3 Global Safety Lancets Sales Market Share by Application (2019-2030)
5.2 Global Safety Lancets Revenue by Application (2019-2030)
5.2.1 Global Safety Lancets Revenue by Application (2019-2024)
5.2.2 Global Safety Lancets Revenue by Application (2025-2030)
5.2.3 Global Safety Lancets Revenue Market Share by Application (2019-2030)
5.3 Global Safety Lancets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Safety Lancets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BD Safety Lancets Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Ascensia
6.3.1 Ascensia Corporation Information
6.3.2 Ascensia Description and Business Overview
6.3.3 Ascensia Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ascensia Safety Lancets Product Portfolio
6.3.5 Ascensia Recent Developments/Updates
6.4 Lifescan
6.4.1 Lifescan Corporation Information
6.4.2 Lifescan Description and Business Overview
6.4.3 Lifescan Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lifescan Safety Lancets Product Portfolio
6.4.5 Lifescan Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B. Braun Safety Lancets Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Safety Lancets Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Nipro
6.6.1 Nipro Corporation Information
6.6.2 Nipro Description and Business Overview
6.6.3 Nipro Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nipro Safety Lancets Product Portfolio
6.7.5 Nipro Recent Developments/Updates
6.8 Cardinal Health
6.8.1 Cardinal Health Corporation Information
6.8.2 Cardinal Health Description and Business Overview
6.8.3 Cardinal Health Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cardinal Health Safety Lancets Product Portfolio
6.8.5 Cardinal Health Recent Developments/Updates
6.9 ARKRAY
6.9.1 ARKRAY Corporation Information
6.9.2 ARKRAY Description and Business Overview
6.9.3 ARKRAY Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ARKRAY Safety Lancets Product Portfolio
6.9.5 ARKRAY Recent Developments/Updates
6.10 ICU Medical
6.10.1 ICU Medical Corporation Information
6.10.2 ICU Medical Description and Business Overview
6.10.3 ICU Medical Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ICU Medical Safety Lancets Product Portfolio
6.10.5 ICU Medical Recent Developments/Updates
6.11 Owen Mumford
6.11.1 Owen Mumford Corporation Information
6.11.2 Owen Mumford Safety Lancets Description and Business Overview
6.11.3 Owen Mumford Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Owen Mumford Safety Lancets Product Portfolio
6.11.5 Owen Mumford Recent Developments/Updates
6.12 HemoCue
6.12.1 HemoCue Corporation Information
6.12.2 HemoCue Safety Lancets Description and Business Overview
6.12.3 HemoCue Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 HemoCue Safety Lancets Product Portfolio
6.12.5 HemoCue Recent Developments/Updates
6.13 Greiner Bio One
6.13.1 Greiner Bio One Corporation Information
6.13.2 Greiner Bio One Safety Lancets Description and Business Overview
6.13.3 Greiner Bio One Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Greiner Bio One Safety Lancets Product Portfolio
6.13.5 Greiner Bio One Recent Developments/Updates
6.14 HTL-STREFA
6.14.1 HTL-STREFA Corporation Information
6.14.2 HTL-STREFA Safety Lancets Description and Business Overview
6.14.3 HTL-STREFA Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.14.4 HTL-STREFA Safety Lancets Product Portfolio
6.14.5 HTL-STREFA Recent Developments/Updates
6.15 Sarstedt
6.15.1 Sarstedt Corporation Information
6.15.2 Sarstedt Safety Lancets Description and Business Overview
6.15.3 Sarstedt Safety Lancets Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sarstedt Safety Lancets Product Portfolio
6.15.5 Sarstedt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Safety Lancets Industry Chain Analysis
7.2 Safety Lancets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Safety Lancets Production Mode & Process
7.4 Safety Lancets Sales and Marketing
7.4.1 Safety Lancets Sales Channels
7.4.2 Safety Lancets Distributors
7.5 Safety Lancets Customers
8 Safety Lancets Market Dynamics
8.1 Safety Lancets Industry Trends
8.2 Safety Lancets Market Drivers
8.3 Safety Lancets Market Challenges
8.4 Safety Lancets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Safety Lancets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Safety Lancets Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Safety Lancets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Safety Lancets Sales (M Units) of Key Manufacturers (2019-2024)
Table 5. Global Safety Lancets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Safety Lancets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Safety Lancets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Safety Lancets Average Price (US$/K Units) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Safety Lancets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Safety Lancets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Safety Lancets, Product Type & Application
Table 12. Global Key Manufacturers of Safety Lancets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Safety Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safety Lancets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Safety Lancets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Safety Lancets Sales by Region (2019-2024) & (M Units)
Table 18. Global Safety Lancets Sales Market Share by Region (2019-2024)
Table 19. Global Safety Lancets Sales by Region (2025-2030) & (M Units)
Table 20. Global Safety Lancets Sales Market Share by Region (2025-2030)
Table 21. Global Safety Lancets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Safety Lancets Revenue Market Share by Region (2019-2024)
Table 23. Global Safety Lancets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Safety Lancets Revenue Market Share by Region (2025-2030)
Table 25. North America Safety Lancets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Safety Lancets Sales by Country (2019-2024) & (M Units)
Table 27. North America Safety Lancets Sales by Country (2025-2030) & (M Units)
Table 28. North America Safety Lancets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Safety Lancets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Safety Lancets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Safety Lancets Sales by Country (2019-2024) & (M Units)
Table 32. Europe Safety Lancets Sales by Country (2025-2030) & (M Units)
Table 33. Europe Safety Lancets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Safety Lancets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Safety Lancets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Safety Lancets Sales by Region (2019-2024) & (M Units)
Table 37. Asia Pacific Safety Lancets Sales by Region (2025-2030) & (M Units)
Table 38. Asia Pacific Safety Lancets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Safety Lancets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Safety Lancets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Safety Lancets Sales by Country (2019-2024) & (M Units)
Table 42. Latin America Safety Lancets Sales by Country (2025-2030) & (M Units)
Table 43. Latin America Safety Lancets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Safety Lancets Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Safety Lancets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Safety Lancets Sales by Country (2019-2024) & (M Units)
Table 47. Middle East & Africa Safety Lancets Sales by Country (2025-2030) & (M Units)
Table 48. Middle East & Africa Safety Lancets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Safety Lancets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Safety Lancets Sales (M Units) by Type (2019-2024)
Table 51. Global Safety Lancets Sales (M Units) by Type (2025-2030)
Table 52. Global Safety Lancets Sales Market Share by Type (2019-2024)
Table 53. Global Safety Lancets Sales Market Share by Type (2025-2030)
Table 54. Global Safety Lancets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Safety Lancets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Safety Lancets Revenue Market Share by Type (2019-2024)
Table 57. Global Safety Lancets Revenue Market Share by Type (2025-2030)
Table 58. Global Safety Lancets Price (US$/K Units) by Type (2019-2024)
Table 59. Global Safety Lancets Price (US$/K Units) by Type (2025-2030)
Table 60. Global Safety Lancets Sales (M Units) by Application (2019-2024)
Table 61. Global Safety Lancets Sales (M Units) by Application (2025-2030)
Table 62. Global Safety Lancets Sales Market Share by Application (2019-2024)
Table 63. Global Safety Lancets Sales Market Share by Application (2025-2030)
Table 64. Global Safety Lancets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Safety Lancets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Safety Lancets Revenue Market Share by Application (2019-2024)
Table 67. Global Safety Lancets Revenue Market Share by Application (2025-2030)
Table 68. Global Safety Lancets Price (US$/K Units) by Application (2019-2024)
Table 69. Global Safety Lancets Price (US$/K Units) by Application (2025-2030)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 73. Roche Safety Lancets Product
Table 74. Roche Recent Developments/Updates
Table 75. BD Corporation Information
Table 76. BD Description and Business Overview
Table 77. BD Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 78. BD Safety Lancets Product
Table 79. BD Recent Developments/Updates
Table 80. Ascensia Corporation Information
Table 81. Ascensia Description and Business Overview
Table 82. Ascensia Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 83. Ascensia Safety Lancets Product
Table 84. Ascensia Recent Developments/Updates
Table 85. Lifescan Corporation Information
Table 86. Lifescan Description and Business Overview
Table 87. Lifescan Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 88. Lifescan Safety Lancets Product
Table 89. Lifescan Recent Developments/Updates
Table 90. B. Braun Corporation Information
Table 91. B. Braun Description and Business Overview
Table 92. B. Braun Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 93. B. Braun Safety Lancets Product
Table 94. B. Braun Recent Developments/Updates
Table 95. Terumo Corporation Information
Table 96. Terumo Description and Business Overview
Table 97. Terumo Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 98. Terumo Safety Lancets Product
Table 99. Terumo Recent Developments/Updates
Table 100. Nipro Corporation Information
Table 101. Nipro Description and Business Overview
Table 102. Nipro Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 103. Nipro Safety Lancets Product
Table 104. Nipro Recent Developments/Updates
Table 105. Cardinal Health Corporation Information
Table 106. Cardinal Health Description and Business Overview
Table 107. Cardinal Health Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 108. Cardinal Health Safety Lancets Product
Table 109. Cardinal Health Recent Developments/Updates
Table 110. ARKRAY Corporation Information
Table 111. ARKRAY Description and Business Overview
Table 112. ARKRAY Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 113. ARKRAY Safety Lancets Product
Table 114. ARKRAY Recent Developments/Updates
Table 115. ICU Medical Corporation Information
Table 116. ICU Medical Description and Business Overview
Table 117. ICU Medical Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 118. ICU Medical Safety Lancets Product
Table 119. ICU Medical Recent Developments/Updates
Table 120. Owen Mumford Corporation Information
Table 121. Owen Mumford Description and Business Overview
Table 122. Owen Mumford Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 123. Owen Mumford Safety Lancets Product
Table 124. Owen Mumford Recent Developments/Updates
Table 125. HemoCue Corporation Information
Table 126. HemoCue Description and Business Overview
Table 127. HemoCue Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 128. HemoCue Safety Lancets Product
Table 129. HemoCue Recent Developments/Updates
Table 130. Greiner Bio One Corporation Information
Table 131. Greiner Bio One Description and Business Overview
Table 132. Greiner Bio One Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 133. Greiner Bio One Safety Lancets Product
Table 134. Greiner Bio One Recent Developments/Updates
Table 135. HTL-STREFA Corporation Information
Table 136. HTL-STREFA Description and Business Overview
Table 137. HTL-STREFA Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 138. HTL-STREFA Safety Lancets Product
Table 139. HTL-STREFA Recent Developments/Updates
Table 140. Sarstedt Corporation Information
Table 141. Sarstedt Description and Business Overview
Table 142. Sarstedt Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 143. Sarstedt Safety Lancets Product
Table 144. Sarstedt Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Safety Lancets Distributors List
Table 148. Safety Lancets Customers List
Table 149. Safety Lancets Market Trends
Table 150. Safety Lancets Market Drivers
Table 151. Safety Lancets Market Challenges
Table 152. Safety Lancets Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Safety Lancets
Figure 2. Global Safety Lancets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Safety Lancets Market Share by Type in 2023 & 2030
Figure 4. Safety Lancets with Needle Product Picture
Figure 5. Safety Lancets with Blade Product Picture
Figure 6. Global Safety Lancets Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Safety Lancets Market Share by Application in 2023 & 2030
Figure 8. Hospital & Clinics
Figure 9. Home
Figure 10. Other
Figure 11. Global Safety Lancets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Safety Lancets Market Size (2019-2030) & (US$ Million)
Figure 13. Global Safety Lancets Sales (2019-2030) & (M Units)
Figure 14. Global Safety Lancets Average Price (US$/K Units) & (2019-2030)
Figure 15. Safety Lancets Report Years Considered
Figure 16. Safety Lancets Sales Share by Manufacturers in 2023
Figure 17. Global Safety Lancets Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Safety Lancets Players: Market Share by Revenue in 2023
Figure 19. Safety Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Safety Lancets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Safety Lancets Sales Market Share by Country (2019-2030)
Figure 22. North America Safety Lancets Revenue Market Share by Country (2019-2030)
Figure 23. United States Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Safety Lancets Sales Market Share by Country (2019-2030)
Figure 26. Europe Safety Lancets Revenue Market Share by Country (2019-2030)
Figure 27. Germany Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Safety Lancets Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Safety Lancets Revenue Market Share by Region (2019-2030)
Figure 34. China Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Safety Lancets Sales Market Share by Country (2019-2030)
Figure 45. Latin America Safety Lancets Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Safety Lancets Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Safety Lancets Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Safety Lancets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Safety Lancets by Type (2019-2030)
Figure 55. Global Revenue Market Share of Safety Lancets by Type (2019-2030)
Figure 56. Global Safety Lancets Price (US$/K Units) by Type (2019-2030)
Figure 57. Global Sales Market Share of Safety Lancets by Application (2019-2030)
Figure 58. Global Revenue Market Share of Safety Lancets by Application (2019-2030)
Figure 59. Global Safety Lancets Price (US$/K Units) by Application (2019-2030)
Figure 60. Safety Lancets Value Chain
Figure 61. Safety Lancets Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
